Driven in part by an unusually large number of big-name disappointments, biotech stocks on the whole have been in decline since February – and whether… Read More »Why Biotech’s Trajectory Could Be Determined In June
With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of… Read More »FDA Approval Of Its Obesity Drug Has This Small Biotech Rocketing Up
Attractive dividend yields do exist in the tech and biotech sectors – if you focus on the right kinds of investment vehicles. Case in point:… Read More »Where To Find Attractive Yields In Tech And Biotech (Such As This One)
If you’re looking for a biotech investment that has been handily beating big biotechs such as Biogen and Gilead Sciences when it comes to returns,… Read More »This Investment Has Been Handily Beating Big Biotechs